Ovarian Cysts Market Research Report: By Type (Functional Cysts, Non-Functional Cysts) By Diagnosis (Imaging, CA-125 Blood Test, Laparoscopy) By Treatment (PCOS Drugs, Surgery) By End Users (Hospitals, Research Organization) - Forecast till 2030

Ovarian Cysts Market Scenario

Ovarian cysts are closed, sac-like structures filled with a liquid or semisolid substance within the ovary. Ovarian cysts are quite common in women who ovulate and the chances for the development of such cysts after menopause are less. However, the formation of ovarian cysts even after menopause is reported. This condition is marked by high risks for ovarian cancer. Most of the ovarian cysts are discovered during a routine pelvic exam. According to a study published in the Journal of Clinical Research in Paediatric Endocrinology in 2017, the frequency of ovarian cysts is about 1.8% in children aged between 5-9 years and 18.8% in those who aged between 10-18 years. Moreover, it is estimated that with the onset of adolescence and increasing age, the frequency of ovarian cysts increases and ranges between 3.8%-31.3%. Such trends in the prevalence of the ovarian cysts are one of the major drivers of the market growth. Moreover, rising healthcare expenditures and increasing awareness about woman health boost the market growth. However, lack of awareness and low per capita healthcare expenditure in the developing countries may restrain the market growth. 

The ovarian cysts market is anticipated to reach USD 2,025 Million at 23.5% CAGR during the forecast period 2022-2030.

Figure 1:- Ovarian Cysts Global Market share, by region

Sources: WHO, annual reports, press release, white paper, and company presentation

 Ovarian Cysts Market Segmentation

The global ovarian cysts market is segmented on the basis of type, diagnosis, treatment, and end users.

On the basis of the type, the ovarian cysts market is segmented into functional cysts, non-functional cysts, and others. The functional cysts segment by type is sub-segmented into the follicular cyst, corpus luteum cyst, and others. The non-functional cysts segment by type is sub-segmented into dermoid cysts, cystadenomas, endometriomas, and others.

On the basis of the diagnosis, the ovarian cysts market is segmented into imaging, CA-125 blood test, laparoscopy, and others. The imaging segment is sub-segmented into CT scan, MRI, ultrasound, and others.

On the basis of the treatment, the ovarian cysts market is segmented into medication, polycystic ovary syndrome (PCOS) drugs, pain relievers, surgery, and others. The pain relievers are sub-segmented into acetaminophen, non-steroidal anti-inflammatory drugs, opioids, and others.

On the basis of the end users, the ovarian cysts market is segmented into hospitals & clinics, medical institutes, research organization, and others.

 Ovarian Cysts Market Regional Analysis

America dominates the global ovarian cysts market owing to a well-developed healthcare sector and huge patient population for ovarian cysts. Apart from this, changing lifestyle and increasing healthcare expenditure have boosted the growth of the ovarian cysts market in America. In 2015, according to the Centres for Disease Control and Prevention, in the U.S. the total healthcare expenditure accounted for 17.8% of the total gross domestic product (GDP), which accounted for USD 3.2 trillion. 

Europe is the second largest ovarian cysts market, which is followed by Asia Pacific. Availability of funds for research, huge patient population, increasing healthcare expenditures, well-developed healthcare sector and government support for research & development are projected to drive the ovarian cysts market growth during the forecasted period. Regionally, Europe is divided into Western Europe and Eastern Europe. Western Europe holds the major share of the regional market, which is majorly contributed by Germany, the U.K., and France. However, Eastern Europe is the fastest growing region due to the huge opportunities in the untapped market. 

Asia Pacific is the fastest growing region in the global ovarian cysts market due to the presence of a huge patient population, continuously developing economies like India and China, and presence of huge opportunity in the market. Moreover, favorable government policies and increasing healthcare expenditures fuel the market growth within the region. 

On the other hand, the Middle East & Africa holds the least share of the global ovarian cysts market due to the presence of poor economy, especially, in the African region. Majority of the market of this region is held by the Middle East due to the well-developed healthcare sector and huge healthcare expenditure by the presence of economies like Kuwait, Saudi Arabia, Dubai, and Qatar.  

Ovarian Cysts Market- Key Players 

Pfizer Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (The Middle East & Africa), Quest Diagnostics Incorporated. (U.S.), Novartis AG (Europe), General Electric Company (Europe), Merck & Co., Inc. (U.S.), Boston Scientific Corporation (U.S.), and Medtronic (U.S)

 Research Methodology 

Sources: WHO, annual reports, press release, white paper, and company presentation 

Intended Audience

• Pharmaceutical companies


• Biotechnological institutes


• Research and Development (R&D) Companies


• Medical Research Laboratories


• Market Research and Consulting Service Providers